Similarly, the elevated cardiomyocyte Fpassive in diabetic patients could be decreased by in vitro CaMKII treatment, but normalization to the levels of treated non-diabetic AS patients was not achieved (Fig. 6H). Here, CAMK2G is linked to aortic valve stenosis.